Tomsk, Russia

Vladimir Chemenko

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2015.


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,350 
Other
 patents

Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vladimir Chemenko: Innovator in Lithotripsy Technology

Introduction

Vladimir Chemenko is a notable inventor based in Tomsk, Russia. He has made significant contributions to the field of medical technology, particularly in the area of lithotripsy. His innovative approach has the potential to improve patient outcomes in the treatment of kidney stones.

Latest Patents

Chemenko holds a patent for a method and apparatus for intracorporeal lithotripsy fragmentation. This method involves electro-impulse intracorporeal lithotripsy, which includes bringing electrodes of a probe into immediate electrical contact with the calculus. By supplying very short high voltage impulses to the electrodes, an electrical spark discharge is ignited, establishing a discharge channel within the bulk of the calculus. This channel creates tensile stresses that effectively destroy the calculus.

Career Highlights

Throughout his career, Chemenko has focused on advancing medical technologies that enhance surgical procedures. His work in lithotripsy represents a significant advancement in non-invasive treatment options for patients suffering from kidney stones.

Collaborations

Chemenko has collaborated with notable professionals in his field, including Valery Diamant and Marat Izrailievich Lerner. These collaborations have contributed to the development and refinement of his innovative techniques.

Conclusion

Vladimir Chemenko's contributions to lithotripsy technology exemplify the impact of innovation in medical treatments. His patented methods offer promising solutions for patients and highlight the importance of continued research and development in this field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…